Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Busulfan")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 670

  • Page / 27
Export

Selection :

  • and

TOXICITY OF BUSULFAN AND INFLUENCE CHEMOSTERILIZED BOLL WEEVILS ON REPRODUCTIVE PERFORMANCE OF THE JAPANESE QUAIL = LA TOXICITE DU BUSULFAN ET L'INFLUENCE DE L'INGESTION D'ANTHONOMUS GRANIDIS STERILISE SUR LA CAPACITE DE REPRODUCTION DE COTURNIX COTURNIX JAPONICAKULKARNI PG; MITLIN N; HURST GA et al.1973; J. ECON. ENTOMOL.; U.S.A.; DA. 1973; VOL. 66; NO 2; PP. 341-343; BIBL. 13 REF.Serial Issue

Intérêt clinique de l'adaptation des posologies du busulfan et de la ciclosporine chez des enfants greffés de moelle osseuse = Busulfan and cycosporin in bone graft childrenBERTOLLE, V; MARTIN, P; BLEYZAC, N et al.Annales pharmaceutiques françaises. 2004, Vol 62, Num 3, pp 165-176, issn 0003-4509, 12 p.Article

High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsBOULIGAND, Jérome; PACI, Angelo; MERCIER, Lionel et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 3, pp 525-530, issn 0731-7085, 6 p.Article

MATING AND STERILITY OF MALE BOLL WEEVILS TREATED WITH BUSULFAN PLUS HEMPA = ACCOUPLEMENT ET STERILITE DES ANTHONOMES MALES TRAITES AU BUSULFAN ADDITIONNE DE HEMPAHAYNES JW; MITLIN N; DAVICH TB et al.1975; ENVIRONMENT. ENTOMOL.; U.S.A.; DA. 1975; VOL. 4; NO 2; PP. 315-318; BIBL. 15 REF.Article

Accidental busulfan overdose during conditioning for stem cell transplantationJENKE, A; FREIBERG-RICHTER, J; WILHELM, S et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 2, pp 125-128, issn 0268-3369, 4 p.Article

I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipientsNGUYEN, L; FULLER, D; LENNON, S et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 10, pp 979-987, issn 0268-3369, 9 p.Article

UNERWUENSCHTE NEBENWIRKUNGEN VON BUSULFAN = EFFETS SECONDAIRES NON DESIRES DU BUSULFANJAPP H.1974; DTSCH. MED. WSCHR.; DTSCH.; DA. 1974; VOL. 99; NO 51; PP. 2614-2615; BIBL. 10REF.Article

Repetitive Busulfan Administration After Hematopoietic Stem Cell Gene Therapy Associated with a Dominant HDAC7 Clone in a Nonhuman PrimateJIANJUN XIE; LAROCHELLE, Andre; MARIC, Irina et al.Human gene therapy. 2010, Vol 21, Num 6, pp 695-703, issn 1043-0342, 9 p.Article

DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effectIWAMOTO, Takuya; HIRAKU, Yusuke; OIKAWA, Shinji et al.Cancer science. 2004, Vol 95, Num 5, pp 454-458, issn 1347-9032, 5 p.Article

Integration of modelling and simulation into the development of intravenous busulfan in paediatrics : an industrial experienceNGUYEN, L.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 599-604, issn 0767-3981, 6 p.Conference Paper

Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablationVENG-PEDERSEN, P; CHAPEL, S; AL-HUNITI, N. H et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 4, pp 149-156, issn 0142-2782, 8 p.Article

Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patientsMUNKELT, Doreen; KOEHL, Ulrike; KLINGEBIEL, Thomas et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 821-830, issn 0344-5704, 10 p.Article

In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phasePREISLER, H. D; KIRSHNER, J.Experimental hematology. 1983, Vol 11, Num 7, pp 618-625, issn 0301-472XArticle

Case report: remission of chronic idiopathic myelofibrosis to busulfan treatmentCHANG, J. C; GROSS, H. M.The American journal of the medical sciences. 1988, Vol 295, Num 5, pp 472-476, issn 0002-9629Article

Determination of busulfan in tablets by NMR spectroscopyTURCZAN, J; LAU-CAM, C.Spectroscopy letters. 1984, Vol 17, Num 6-7, pp 353-359, issn 0038-7010Article

Population pharmacokinetics of intravenous busulfan in children: revised body weight-dependent NONMEM® model to optimize dosingDIESTELHORST, Christian; BOOS, Joachim; MCCUNE, Jeannine S et al.European journal of clinical pharmacology. 2014, Vol 70, Num 7, pp 839-847, issn 0031-6970, 9 p.Article

Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administrationTRAME, Mirjam N; BARTELINK, Imke H; BOOS, Joachim et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 5, pp 1149-1155, issn 0344-5704, 7 p.Article

Differential effects of busulfan on gonadal development in five divergent anuran speciesPIPREK, Rafał P; PECIO, Anna; KUBIAK, Jacek Z et al.Reproductive toxicology (Elmsford, NY). 2012, Vol 34, Num 3, pp 393-401, issn 0890-6238, 9 p.Article

Individual dose adjustment of oral busulfan using a test dose in hematopoietic stem cell transplantationTAKAMATSU, Yasushi; SASAKI, Noriaki; ETO, Tetsuya et al.International journal of hematology. 2007, Vol 86, Num 3, pp 261-268, issn 0925-5710, 8 p.Article

Intravenous busulfan in adults prior to haematopoietic stem cell transplantation : a population pharmacokinetic studyNGUYEN, L; LEGER, F; LENNON, S et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 2, pp 191-198, issn 0344-5704, 8 p.Article

Monitoring of N,N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography-mass spectrometryOECHTENNG, Doris; BOOS, Joachim; HEMPEL, Georg et al.Journal of chromatography. B. 2006, Vol 838, Num 2, pp 129-134, issn 1570-0232, 6 p.Article

UN CAS D'APLASIE MEDULLAIRE, A LA SUITE D'UNE PRISE UNIQUE D'UNE DOSE DE MYELOSANEMASLOV EN; GELENKO AM.1973; PROBL. GEMATOL. PERELIV. KROVI; S.S.S.R.; DA. 1973; VOL. 18; NO 1; PP. 59Serial Issue

Advances in the treatment of chronic granulomatous disease by gene therapyOTT, Marion G; SEGER, Reinhard; STEIN, Stefan et al.Current gene therapy. 2007, Vol 7, Num 3, pp 155-161, issn 1566-5232, 7 p.Article

Population pharmacokiinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantationTAKAMA, H; TANAKA, H; NAKASHIMA, D et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 4, pp 345-351, issn 0268-3369, 7 p.Article

Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicityZWAVELING, J; BREDIUS, R. G. M; CREMERS, Sclm et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 1, pp 17-23, issn 0268-3369, 7 p.Article

  • Page / 27